Furthermore, a panel of circulating cytokines which includes BLC, M-CSF, Eotaxin-2, and TIMP-1, was identified to have the capability of reflecting inflammatory status in BM niche, which could be potentially served as biomarkers for the diagnosis of MPN subtypes and the prediction of fibrosis progression. The gene discussed is CCL24; the disease is myeloproliferative disorder.